当前位置:产品中心>单抗/多抗

Anti-Human IL-31 Reference Antibody|抗人IL-31参考抗体(靶标:人白细胞介素-31)

货号:RB9T37015528
  • 价格:面议
  • 点击数:440
  

产品介绍

产品参数

形态Liquid
宿主种属Felinized
克隆性Monoclonal
抗体亚型IgG1-kappa
纯度>95% purity as determined by SDS-PAGE.
纯化方式Protein A/G purified from cell culture supernatant.
浓度1mg/ml
内毒素水平Please contact the lab for this information.
应用ELISA, Bioactivity: FACS, Functional assay, Research in vivo
种属反应性Cat
靶标IL-31, Interleukin-31, IL31
储存缓冲液0.01M PBS, pH 7.4.
稳定性和储存Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C for short-term storage (1-2 weeks). Store at -20°C for up to 12 months. For long-term storage, store at -80°C.
表达系统Mammalian Cells
登录号A0A2I2UKP7
背景信息Dovanvetmab (ZTS-00521505) is an IgG1-κ antibody targeting Felcat IL31. Mainly expressed by CHO (Chinese Hamster Ovary) cells.<br>• The IL-4, IL-13 and IL-31 pathways in atopic dermatitis., PMID:34106037<br/>• IL-31-dependent neurogenic inflammation restrains cutaneous type 2 immune response in allergic dermatitis., PMID:37831760<br/>• Interleukin-31: The "itchy" cytokine in inflammation and therapy., PMID:33629401<br/>• A sensory neuron-expressed IL-31 receptor mediates T helper cell-dependent itch: Involvement of TRPV1 and TRPA1., PMID:24373353<br/>• Seladelpar treatment reduces IL-31 and pruritus in patients with primary biliary cholangitis., PMID:38117036<br/>• Nemolizumab: First Approval., PMID:35834124<br/>• Nemolizumab: An Innovative Biologic Treatment to Control Interleukin 31, a Key Mediator in Atopic Dermatitis and Prurigo Nodularis., PMID:35842249<br/>• The Cytokine TGF-β Induces Interleukin-31 Expression from Dermal Dendritic Cells to Activate Sensory Neurons and Stimulate Wound Itching., PMID:32673566<br/>• Pruritus as a Distinctive Feature of Type 2 Inflammation., PMID:33807098<br/>• Targeting Interleukin-31 in Prurigo., PMID:37888922<br/>
别名ZTS-00521505, 2171034-71-0
备注For research use only. Not suitable for clinical or therapeutic use.